Healthcare
Intra-Cellular Therapies, Inc. (ITCI)
64/ 100 Tessera Quality Score
Snapshot
- Market Cap
- $14.0B
- P/E
- —
- Sector Median P/E
- 26.6
- F-Score
- 4/9
- ROIC
- -2.5%
- FCF Yield
- -0.5%
ITCI has a Tessera Quality Score of 63, placing it in the top 50% of the Healthcare sector. Piotroski F-Score is 4/9; trailing ROIC is -2.5%.
Sector Peers
- Takeda Pharmaceutical Company Limited (TAK)Mkt Cap: $49.4B · FCF: 16.7%
- Haleon plc (HLN)Mkt Cap: $39.6B · FCF: 11.9%
- Teva Pharmaceutical Industries Limited (TEVA)Mkt Cap: $36.7B · FCF: 6.8%
- Viatris Inc. (VTRS)Mkt Cap: $17.9B · FCF: 11.7%
- Elanco Animal Health Incorporated (ELAN)Mkt Cap: $12.1B · FCF: 6.4%